Results from a phase I study of KL590586 in patients with advanced RET-mutant medullary thyroid cancer.

Authors
Category Primary study
ConferenceASCO MEETING ABSTRACTS
Year 2025
This article has no abstract
Epistemonikos ID: 9de0bf3f268c4d25f63f4ad362ba423c929a71a5
First added on: May 16, 2026